Skip to main content
Caplight Logo









Aferna Bio

Aferna Bio

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.afernabio.com/

Last Round

VC Round

Jun 4, 2025

Company Overview

Aferna Bio is an agtech company that develops ribonucleic acid-based molecular tools to create beneficial crop traits by working in partnership with nature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

agricultural biotechnologyRNA methylationepigeneticscrop trait developmentagtechgene expressionmolecular biologycrop resiliencenon-GMObiotech R&Dplant breedinggenomicsbiotech licensingsynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aferna Bio Comparables

Compare Aferna Bio with similar companies based on industry and business-model similarity.

Aferna Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Terrana Biosciences
88%
Decibel Bio
84%
Epicrop Technologies
81%

Aferna Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 4, 2025
SeedJan 1, 2022

Key People

Founding team and executive leadership

Jon Schmuke

President & Chief Technology Officer

Executive Team

Aferna Bio Investors

Notable investors and investment history

Aferna Bio investors
InvestorRounds
BioGenerator VenturesSeed
Plaisance Capital ManagementSeed
Leaps by BayerVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2025

    $4M round with participation from Leaps by Bayer.

  • Jan 1, 2022

    Seed round raised with participation from Leaps by Bayer and BioGenerator Ventures.

Aferna Bio Filings

Explore SEC and related filing metadata, where available.

Aferna Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aferna Bio's valuation, stock price, and market status.

Is Aferna Bio a public or private company?

Aferna Bio is a private company.

What is the current stock price of Aferna Bio?

Aferna Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Aferna Bio worth (valuation)?

Valuation information for Aferna Bio is not publicly available.

Can I buy Aferna Bio stock?

Aferna Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aferna Bio's last funding round?

Aferna Bio's most recent funding round was Seed on January 1, 2022.

Who are the main investors in Aferna Bio?

Key investors in Aferna Bio include BioGenerator Ventures, Plaisance Capital Management, Leaps by Bayer.

Will Aferna Bio IPO soon?

No public IPO plans have been announced for Aferna Bio.

How can I track Aferna Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aferna Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range6
Year Founded2022
Last FundingJun 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?